Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
VolitionRx Limited (NYSE MKT: VNRX) today announced the publication of a research paper entitled "Circulating nucleosomes as new blood-based...
VolitionRx Limited (NYSE MKT: VNRX) today announced that it will attend the BTIG 2017 Medical Technology, Life Sciences, and Diagnostics Conference...
VolitionRx Limited (NYSE MKT: VNRX) today announced that the Company achieved CE marking on its Nu.QTM Colorectal Cancer Screening Triage Test on...
VolitionRx Limited (NYSE MKT: VNRX) today announced that it will present at the 9th Annual Biotech Showcase Conference being held from January 9-11,...
VolitionRx Limited (NYSE MKT: VNRX), a life sciences company focused on developing diagnostic tests for cancer, today announced that Professor Hans...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.